Dr. Maciej Paszkowski-Rogacz is the Head of Bioinformatics at Seamless Therapeutics, leading a team of biologists and data scientists focused on therapeutic genome engineering. With a PhD from Technische Universität Dresden and extensive research experience at the Max Planck Institute, he is described by colleagues as a skilled, professional, and reliable specialist in computational biology.
He is a key scientific contributor to the "RecTech - Precision Genome Surgery" platform, which develops novel designer recombinases for transformative therapeutic applications.
Maciej Paszkowski-Rogacz, PhD
Head of Bioinformatics at Seamless Therapeutics
Dresden, Saxony, Germany
Overview
Topics They Care About
Genome Engineering
His career is dedicated to creating transformative genome engineering tools and leveraging their potential for new therapeutic applications.
Bioinformatics Leadership
He guides a collaborative team of biologists and data science experts to analyze complex genomic data and unravel the mysteries of recombinases.
Recombinase Technology
His research focuses on developing and applying novel "designer recombinases" for precision gene editing, forming the core of his company's technology.
Media Appearances
Maciej has no verified media appearances
Work History
3-2019
Head of Bioinformatics at Seamless Therapeutics
1-2011 - 12-2023
Staff Scientist at Universitätsklinikum Carl Gustav Carus
5-2010 - 1-2011
Postdoc at Max Planck Institute of Molecular Cell Biology and Genetics
4-2006 - 4-2010
PhD student at Max Planck Institute of Molecular Cell Biology and Genetics
12-2005 - 3-2006
Visiting scientist at BIOTEC (Biotechnolgisches Zentrum der TU Dresden)
2-2005 - 6-2005
Exchange student at Department of Electronics and Information Systems, Gent University
Education
2006 - 2010
PhD from Technische Universität Dresden
2005 - 2005
Computer Science from Ghent University
More Information
Social Presence :
Prographics :
Exp : 20
Location : Dresden, Saxony, Germany
Job Level : Mid-senior
Designation : Head of Bioinformatics at Seamless Therapeutics
